tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating on AbSci: Strategic Developments and Undervalued Commercial Potential
PremiumRatingsBuy Rating on AbSci: Strategic Developments and Undervalued Commercial Potential
25d ago
Absci files $400M mixed securities shelf
Premium
The Fly
Absci files $400M mixed securities shelf
25d ago
Absci Reports Strong Q2 2025 Financial Results
Premium
Company Announcements
Absci Reports Strong Q2 2025 Financial Results
25d ago
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
PremiumMarket NewsCRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
1M ago
Absci price target lowered to $6.40 from $7 at Morgan Stanley
Premium
The Fly
Absci price target lowered to $6.40 from $7 at Morgan Stanley
1M ago
AbSci’s Strategic Growth and Innovation: Analyst Recommends Buy with $6.40 Price Target
Premium
Ratings
AbSci’s Strategic Growth and Innovation: Analyst Recommends Buy with $6.40 Price Target
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100